End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13.84 CNY | -2.12% | -2.95% | -41.13% |
Apr. 25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
Apr. 24 | Walvax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.13% | 3.06B | |
-4.62% | 87.53B | |
+2.63% | 40.42B | |
-21.76% | 29.48B | |
+58.56% | 25.43B | |
-14.78% | 15.59B | |
-18.49% | 11.49B | |
-15.61% | 11.1B | |
-44.02% | 11.3B | |
+5.17% | 8.75B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology Buys Back 170,000 Shares; Stock Rises 3%